| 利用者成果(英) |
|
21740
Shiba-Ishii A, Isagawa T, Shiozawa T, Mato N, Nakagawa T, Takada Y, Hirai K, Hong J, Saitoh A, Takeda N, Niki T, Murakami Y, Matsubara D.
Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC.
Biochim Biophys Acta Mol Basis Dis
2024
167249
PubMed ID: 38768929
DOI: 10.1016/j.bbadis.2024.167249
|
|
22524
Kasai F, Fukushima M, Miyagi Y, Nakamura Y.
Genetic diversity among the present Japanese population: evidence from genotyping of human cell lines established in Japan
Hum Cell
2024
37(4):944-950
PubMed ID: 38639832
DOI: 10.1007/s13577-024-01055-0
|
|
21413
Miyazaki I, Odintsov I, Ishida K, Lui AJW, Kato M, Suzuki T, Zhang T, Wakayama K, Kurth RI, Cheng R, Fujita H, Delasos L, Vojnic M, Khodos I, Yamada Y, Ishizawa K, Mattar MS, Funabashi K, Chang Q, Ohkubo S, Yano W, Terada R, Giuliano C, Lu YC, Bonifacio A, Kunte S, Davare MA, Cheng EH, de Stanchina E, Lovati E, Iwasawa Y, Ladanyi M, Somwar R.
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Nat Cancer
2023
4(9):1345-1361
PubMed ID: 37743366
DOI: 10.1038/s43018-023-00630-y
|
|
17596
Hirai S, Idogawa M, Sumi T, Yamaguchi M, Niki T, Sakuma Y.
Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells
Biochem Biophys Res Commun
2022
630:24-29
PubMed ID: 36126466
DOI: 10.1016/j.bbrc.2022.09.039
|
|
20933
Suphakhong K, Terashima M, Wanna-Udom S, Takatsuka R, Ishimura A, Takino T, Suzuki T.
m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-β-induced epithelial-mesenchymal transition of lung cancer cells.
J Biol Chem
2022
298(11):102554
PubMed ID: 36183833
DOI: 10.1016/j.jbc.2022.102554
|
|
22528
Kooijman JJ, van Riel WE, Dylus J, Prinsen MBW, Grobben Y, de Bitter TJJ, van Doornmalen AM, Melis JJTM, Uitdehaag JCM, Narumi Y, Kawase Y, de Roos JADM, Willemsen-Seegers N, Zaman GJR.
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020
Front Oncol
2022
12:953013
PubMed ID: 36185300
DOI: 10.3389/fonc.2022.953013
|
|
13332
Hase H, Aoki M, Matsumoto K, Nakai S, Nagata T, Takeda A, Ueda K, Minami K, Kitae K, Jingushi K, Ueda Y, Yamamoto M, Furukawa T, Sato M, Tsujikawa K.
Cancer type‑SLCO1B3 promotes epithelial‑mesenchymal transition resulting in the tumour progression of non‑small cell lung cancer.
Oncol Rep
2021
PubMed ID: 33155667
DOI: 10.3892/or.2020.7839
|
|
20104
Abe K, Kanehira M, Ohkouchi S, Kumata S, Suzuki Y, Oishi H, Noda M, Sakurada A, Miyauchi E, Fujiwara T, Harigae H, Okada Y.
Targeting stanniocalcin-1-expressing tumor cells elicits efficient antitumor effects in a mouse model of human lung cancer.
Cancer Med
2021
PubMed ID: 33826244
DOI: 10.1002/cam4.3852
|
|
20304
Nakasone S, Suzuki A, Okazaki H, Onodera K, Zenkoh J, Ishii G, Suzuki Y, Tsuboi M, Tsuchihara K.
Predictive markers based on transcriptome modules for vinorelbine-based adjuvant chemotherapy for lung adenocarcinoma patients.
Lung Cancer
2021
158:115-125
PubMed ID: 34157583
DOI: 10.1016/j.lungcan.2021.06.011
|
|
12021
Wanna-Udom S, Terashima M, Lyu H, Ishimura A, Takino T, Sakari M, Tsukahara T, Suzuki T.
The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.
Biochem. Biophys. Res. Commun.
2020
PubMed ID: 31982139
DOI: 10.1016/j.bbrc.2020.01.042
|
|
12063
Kuchitsu Y, Nagashio R, Igawa S, Kusuhara S, Tsuchiya B, Ichinoe M, Satoh Y, Naoki K, Murakumo Y, Saegusa M, Sato Y.
TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma.
Biomed. Res.
2020
PubMed ID: 32092740
DOI: 10.2220/biomedres.41.53
|
|
13900
Fujimura T, Furugaki K, Harada N, Yoshimura Y.
Enhanced antitumor effect of alectinib in combination with cyclin-dependent kinase 4/6 inhibitor against RET-fusion-positive non-small cell lung cancer cells
Cancer Biol Ther
2020
21(9):863-870
PubMed ID: 32835580
DOI: 10.1080/15384047.2020.1806643
|
|
14832
Saito S, Kitamura-Muramatsu Y, Komine F, Polat M, Takeshima SN, Takei M, Aida Y.
Absence of bovine leukemia virus proviral DNA in Japanese human blood cell lines and human cancer cell lines
Arch Virol
2020
165(1):207-214
PubMed ID: 31776677
DOI: 10.1007/s00705-019-04474-9
|
|
11833
Hiyoshi Y, Sato Y, Ichinoe M, Nagashio R, Hagiuda D, Kobayashi M, Kusuhara S, Igawa S, Shiomi K, Goshima N, Murakumo Y, Saegusa M, Satoh Y, Masuda N, Naoki K.
Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
Thorac Cancer
2019
PubMed ID: 31583841
DOI: 10.1111/1759-7714.13200
|
|
11040
Koh Furugaki, Marie Mochizuki, Mirei Kohno, Sei Shu, Naoki Harada, Yasushi Yoshimura
Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
BMC Cancer
2019
19(1):301
PubMed ID: 30943926
DOI: 10.1186/s12885-019-5527-2
|
|
12502
Hagiuda D, Nagashio R, Ichinoe M, Tsuchiya B, Igawa S, Naoki K, Satoh Y, Murakumo Y, Saegusa M, Sato Y.
Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma
Biomed Res
2019
40(1):17-27
PubMed ID: 30787260
DOI: 10.2220/biomedres.40.17
|
|
11149
Shimizu K, Okita R, Saisho S, Maeda AI, Nojima Y, Nakata M.
Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer.
Anticancer Res.
2018
38(8):4637-4644
PubMed ID: 30061230
DOI: 10.21873/anticanres.12768
|
|
11223
Terashima M, Ishimura A, Wanna-Udom S, Suzuki T.
MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells.
J. Biol. Chem.
2018
PubMed ID: 30262664
DOI: 10.1074/jbc.RA118.004006
|
|
4183
Ohara K, Ohkuri T, Kumai T, Nagato T, Nozaki Y, Ishibashi K, Kosaka A, Nagata M, Harabuchi S, Ohara M, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H.
Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.
Oncoimmunology
2018
PubMed ID: 30510853
DOI: 10.1080/2162402X.2018.1466771
|
|
9949
Chang H, Sung JH, Moon SU, Kim HS, Kim JW, Lee JS.
EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells.
Yonsei Med. J.
2017
58:9-18
PubMed ID: 27873490
DOI: 10.3349/ymj.2017.58.1.9
|
|
9950
Terashima M, Tange S, Ishimura A, Suzuki T.
MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
J. Biol. Chem.
2017
292:82-99
PubMed ID: 27852821
DOI: 10.1074/jbc.M116.750950
|
|
10280
Seike M, Kim CH, Zou F, Noro R, Chiba M, Ishikawa A, Κunugi S, Kubota K, Gemma A.
AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
Oncol. Rep.
2017
37:3261-3269
PubMed ID: 28440492
DOI: 10.3892/or.2017.5594
|
|
10408
Terashima M, Ishimura A, Wanna-Udom S, Suzuki T.
Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells.
Biochem. Biophys. Res. Commun.
2017
490:1407-1413
PubMed ID: 28698146
DOI: 10.1016/j.bbrc.2017.07.048
|
|
10464
Reeser JW, Martin D, Miya J, Kautto EA, Lyon E, Zhu E, Wing MR, Smith A, Reeder M, Samorodnitsky E, Parks H, Naik KR, Gozgit J, Nowacki N, Davies KD, Varella-Garcia M, Yu L, Freud AG, Coleman J, Aisner DL, Roychowdhury S.
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.
J Mol Diagn
2017
19:682-696
PubMed ID: 28802831
DOI: 10.1016/j.jmoldx.2017.05.006
|
|
10922
Shigeaki Umeda et al
Loss of IL-24 expression facilitates invasion in lung adenocarcinoma
Int J Clin Exp Pathol
2017
10:173-185
|
|
14222
Horie M, Kaczkowski B, Ohshima M, Matsuzaki H, Noguchi S, Mikami Y, Lizio M, Itoh M, Kawaji H, Lassmann T, Carninci P, Hayashizaki Y, Forrest ARR, Takai D, Yamaguchi Y, Micke P, Saito A, Nagase T.
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC
Mol Cancer Res
2017
15(10):1354-1365
PubMed ID: 28698358
DOI: 10.1158/1541-7786.MCR-17-0191
|
|
14232
Yasunaga M, Manabe S, Matsumura Y.
Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease
Sci Rep
2017
7(1):10735
PubMed ID: 28878234
DOI: 10.1038/s41598-017-11255-4
|
|
14355
Okita R, Maeda A, Shimizu K, Nojima Y, Saisho S, Nakata M.
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer
Cancer Immunol Immunother
2017
66(7):865-876
PubMed ID: 28341875
DOI: 10.1007/s00262-017-1986-y
|
|
9522
Nishijima N, Seike M, Soeno C, Chiba M, Miyanaga A, Noro R, Sugano T, Matsumoto M, Kubota K, Gemma A.
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells.
Int. J. Oncol.
2016
48:937-44
PubMed ID: 26783187
DOI: 10.3892/ijo.2016.3331
|
|
12967
Okita R, Yukawa T, Nojima Y, Maeda A, Saisho S, Shimizu K, Nakata M.
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer
Cancer Immunol Immunother
2016
65(5):499-509.
PubMed ID: 26940474
DOI: 10.1007/s00262-016-1814-9
|
|
13983
Ito T, Matsubara D, Tanaka I, Makiya K, Tanei ZI, Kumagai Y, Shiu SJ, Nakaoka HJ, Ishikawa S, Isagawa T, Morikawa T, Shinozaki-Ushiku A, Goto Y, Nakano T, Tsuchiya T, Tsubochi H, Komura D, Aburatani H, Dobashi Y, Nakajima J, Endo S, Fukayama M, Sekido Y, Niki T, Murakami Y.
Loss of YAP1 defines neuroendocrine differentiation of lung tumors
Cancer Sci
2016
107(10):1527-1538
PubMed ID: 27418196
DOI: 10.1111/cas.13013
|
|
15849
Paweletz CP, Sacher AG, Raymond CK, Alden RS, O'Connell A, Mach SL, Kuang Y, Gandhi L, Kirschmeier P, English JM, Lim LP, Jänne PA, Oxnard GR.
Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients
Clin Cancer Res
2016
22(4):915-22
PubMed ID: 26459174
DOI: 10.1158/1078-0432.CCR-15-1627-T
|
|
16655
Okudela K, Mitsui H, Woo T, Kojima Y, Matsumura M, Arai H, Suzuki T, Umeda S, Tateishi Y, Saito Y, Tajiri M, Masuda M, Kameda Y, Ohashi K.
Expression of tropomyosins in lung cancer - a potential role in carcinogenesis and its utility in a histopathological diagnosis
Histol Histopathol
2016
31(8):857-66
PubMed ID: 26750107
DOI: 10.14670/HH-11-721
|
|
7452
Liu G, Wu Q, Liu G, Song X, Zhang J.
Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans.
Cancer Cell Int.
2015
15:18
PubMed ID: 25745359
DOI: 10.1186/s12935-014-0154-0
|
|
14286
Katono K, Sato Y, Jiang SX, Kobayashi M, Nagashio R, Ryuge S, Fukuda E, Goshima N, Satoh Y, Saegusa M, Masuda N.
Prognostic significance of MYH9 expression in resected non-small cell lung cancer
PLoS One
2015
10(3):e0121460
PubMed ID: 25826333
DOI: 10.1371/journal.pone.0121460
|
|
14314
Okita R, Wolf D, Yasuda K, Maeda A, Yukawa T, Saisho S, Shimizu K, Yamaguchi Y, Oka M, Nakayama E, Lundqvist A, Kiessling R, Seliger B, Nakata M.
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
PLoS One
2015
10(10):e0139809
PubMed ID: 26439264
DOI: 10.1371/journal.pone.0139809
|
|
15025
Suzuki A, Matsushima K, Makinoshima H, Sugano S, Kohno T, Tsuchihara K, Suzuki Y.
Single-cell analysis of lung adenocarcinoma cell lines reveals diverse expression patterns of individual cells invoked by a molecular target drug treatment
Genome Biol
2015
16(1):66
PubMed ID: 25887790
DOI: 10.1186/s13059-015-0636-y
|
|
15117
Sugano T, Seike M, Noro R, Soeno C, Chiba M, Zou F, Nakamichi S, Nishijima N, Matsumoto M, Miyanaga A, Kubota K, Gemma A.
Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer
Mol Cancer Ther
2015
14(11):2433-40
PubMed ID: 26351321
DOI: 10.1158/1535-7163.MCT-15-0050
|
|
15123
Kang CW, Jang KW, Sohn J, Kim SM, Pyo KH, Kim H, Yun MR, Kang HN, Kim HR, Lim SM, Moon YW, Paik S, Kim DJ, Kim JH, Cho BC.
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma
Mol Cancer Ther
2015
14(10):2238-48
PubMed ID: 26208525
DOI: 10.1158/1535-7163.MCT-15-0350
|
|
15182
Saito K, Kobayashi M, Nagashio R, Ryuge S, Katono K, Nakashima H, Tsuchiya B, Jiang SX, Saegusa M, Satoh Y, Masuda N, Sato Y.
S100A16 is a Prognostic Marker for Lung Adenocarcinomas
Asian Pac J Cancer Prev
2015
16(16):7039-44
PubMed ID: 26514487
DOI: 10.7314/apjcp.2015.16.16.7039
|
|
15456
Yanagita K, Nagashio R, Ryuge S, Katono K, Jiang SX, Tsuchiya B, Nakashima H, Fukuda E, Goshima N, Saegusa M, Satoh Y, Masuda N, Sato Y.
Serum Anti-Gal-3 Autoantibody is a Predictive Marker of the Efficacy of Platinum-Based Chemotherapy against Pulmonary Adenocarcinoma
Asian Pac J Cancer Prev
2015
16(17):7959-65
PubMed ID: 26625826
DOI: 10.7314/apjcp.2015.16.17.7959
|
|
4866
Kodama T, Tsukaguchi T, Satoh Y, Yoshida M, Watanabe Y, Kondoh O, Sakamoto H.
Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer.
Mol Cancer Ther
2014
13(12):2910-8
PubMed ID: 25349307
DOI: 10.1158/1535-7163.MCT-14-0274
|
|
15845
Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A.
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells
Mol Cancer Ther
2014
13(2):444-53
PubMed ID: 24258346
DOI: 10.1158/1535-7163.MCT-13-0448
|
|
16607
Okudela K, Suzuki T, Umeda S, Tateishi Y, Mitsui H, Miyagi Y, Ohashi K.
A comprehensive search for microRNAs with expression profiles modulated by oncogenic KRAS: potential involvement of miR-31 in lung carcinogenesis
Oncol Rep
2014
32(4):1374-84
PubMed ID: 25050641
DOI: 10.3892/or.2014.3339
|
|
7714
Huqun, Ishikawa R, Zhang J, Miyazawa H, Goto Y, Shimizu Y, Hagiwara K, Koyama N.
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer.
Cancer
2012
118:1599-606
PubMed ID: 21837672
DOI: 10.1002/cncr.26441
|
|
14287
Kobayashi M, Matsumoto T, Ryuge S, Yanagita K, Nagashio R, Kawakami Y, Goshima N, Jiang SX, Saegusa M, Iyoda A, Satoh Y, Masuda N, Sato Y.
CAXII Is a sero-diagnostic marker for lung cancer
PLoS One
2012
7(3):e33952
PubMed ID: 22439015
DOI: 10.1371/journal.pone.0033952
|
|
16490
Shiba-Ishii A, Noguchi M.
Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma
Am J Pathol
2012
180(4):1653-62
PubMed ID: 22310466
DOI: 10.1016/j.ajpath.2011.12.014
|
|
16147
Kageyama T, Nagashio R, Ryuge S, Matsumoto T, Iyoda A, Satoh Y, Masuda N, Jiang SX, Saegusa M, Sato Y.
HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer
Asian Pac J Cancer Prev
2011
12(12):3457-63
PubMed ID: 22471497
|
|
16488
Shiba-Ishii A, Kano J, Morishita Y, Sato Y, Minami Y, Noguchi M.
High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma
Int J Cancer
2011
129(10):2445-53
PubMed ID: 21207417
DOI: 10.1002/ijc.25907
|
|
16553
Hayashi S, Kumai T, Matsuda Y, Aoki N, Sato K, Kimura S, Kitada M, Tateno M, Celis E, Kobayashi H.
Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
J Transl Med
2011
9:191
PubMed ID: 22053850
DOI: 10.1186/1479-5876-9-191
|
|
15847
Mizutani H, Okano T, Minegishi Y, Matsuda K, Sudoh J, Kitamura K, Noro R, Soeno C, Yoshimura A, Seike M, Gemma A.
HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner
Oncol Lett
2010
1(6):1011-1016
PubMed ID: 22870103
DOI: 10.3892/ol.2010.190
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
2481
Okudela K, Yazawa T, Woo T, Sakaeda M, Ishii J, Mitsui H, Shimoyamada H, Sato H, Tajiri M, Ogawa N, Masuda M, Takahashi T, Sugimura H, Kitamura H.
Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis.
Am J Pathol
2009
175(2):867-81
PubMed ID: 19608870
DOI: 10.2353/ajpath.2009.080489
|
|
12769
Okudela K, Yazawa T, Ishii J, Woo T, Mitsui H, Bunai T, Sakaeda M, Shimoyamada H, Sato H, Tajiri M, Ogawa N, Masuda M, Sugimura H, Kitamura H.
Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis
Am J Pathol
2009
175(6):2646-56
PubMed ID: 19893046
DOI: 10.2353/ajpath.2009.080571
|
|
3580
Ito T, Maki N, Hazeki O, Sasaki K, Nekooki M.
Extracellular and transmembrane region of a podocalyxin-like protein 1 fragment identified from colon cancer cell lines.
Cell Biol Int
2007
31(12):1518-24
PubMed ID: 17719804
DOI: 10.1016/j.cellbi.2007.06.017
|
|
17469
Takiguchi Y, Miyamoto T, Nagao K, Kuriyama T.
Assessment of the homogeneous efficacy of carbon ions in the spread-out Bragg peak for human lung cancer cell lines
Radiat Med
2007
25(6):272-7
PubMed ID: 17634880
DOI: 10.1007/s11604-007-0134-6
|
|
3061
Nagai, Yoshiaki, Miyazawa, Hitoshi, Tanaka, Tomoaki, Udagawa, Kiyoshi, Kato, Motoyasu, Fukuyama, Shunichiro, Yokote, Akemi, Kobayashi, Kunihiko, Kanazawa, Minoru, Hagiwara, Koichi, Hagiwara K
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.
Cancer Res
2005
65:7276-82
PubMed ID: 16105816
DOI: 10.1158/0008-5472.CAN-05-0331
|
|
13698
Matsubara D, Niki T, Ishikawa S, Goto A, Ohara E, Yokomizo T, Heizmann CW, Aburatani H, Moriyama S, Moriyama H, Nishimura Y, Funata N, Fukayama M.
Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes
Cancer Sci
2005
96(12):844-57
PubMed ID: 16367903
DOI: 10.1111/j.1349-7006.2005.00121.x
|
|
16489
Seike M, Kondo T, Fujii K, Okano T, Yamada T, Matsuno Y, Gemma A, Kudoh S, Hirohashi S.
Proteomic signatures for histological types of lung cancer
Proteomics
2005
5(11):2939-48
PubMed ID: 15996008
DOI: 10.1002/pmic.200401166
|
|
3338
Seike, Masahiro, Kondo, Tadashi, Fujii, Kazuyasu, Yamada, Tesshi, Gemma, Akihiko, Kudoh, Shoji, Hirohashi, Setsuo
Proteomic signature of human cancer cells.
Proteomics
2004
4:2776-88
PubMed ID: 15352251
DOI: 10.1002/pmic.200300795
|
|
13743
Niki T, Kohno T, Iba S, Moriya Y, Takahashi Y, Saito M, Maeshima A, Yamada T, Matsuno Y, Fukayama M, Yokota J, Hirohashi S.
Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas
Am J Pathol
2002
160(3):1129-41
PubMed ID: 11891209
DOI: 10.1016/s0002-9440(10)64933-4
|
|
16486
Mase K, Iijima T, Nakamura N, Takeuchi T, Onizuka M, Mitsui T, Noguchi M.
Intrabronchial orthotopic propagation of human lung adenocarcinoma--characterizations of tumorigenicity, invasion and metastasis
Lung Cancer
2002
36(3):271-6
PubMed ID: 12009237
DOI: 10.1016/s0169-5002(02)00004-1
|
|
2002
Fukunaga Y, Bandoh S, Fujita J, Yang Y, Ueda Y, Hojo S, Dohmoto K, Tojo Y, Takahara J, Ishida T.
Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients
Lung Cancer
2002
38(1):31-8
PubMed ID: 12367790
DOI: 10.1016/s0169-5002(02)00109-5
|
|
6175
Arai K, Teratani T, Nozawa R, Yamada T.
Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation.
Oncol Rep
2001
8(3):591-6
PubMed ID: 11295086
DOI: 10.3892/or.8.3.591
|
|
2483
Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S
Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
Clin Cancer Res
2000
6:2431-9
PubMed ID: 10873096
|
|
1505
Shiraishi M, Chuu YH, Sekiya T.
Isolation of DNA fragments associated with methylated CpG islands in human adenocarcinomas of the lung using a methylated DNA binding column and denaturing gradient gel electrophoresis
Proc Natl Acad Sci U S A
1999
96(6):2913-8
PubMed ID: 10077611
DOI: 10.1073/pnas.96.6.2913
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト